Bruker Corp (BRKR)

$70.05 0.05 (0.06%)

16:00 EDT BRKR Stock Quote Delayed 30 Minutes

BRKR Stock Earnings: Bruker Beats EPS, Misses Revenue for Q1 2024

By InvestorPlace Earnings May 2, 2024

BRKR stock results show that Bruker beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.

The 3 Best Nasdaq Stocks to Buy in February 2024

The 3 Most Promising Biotech Stocks to Buy Now

7 Stocks to Buy That Could Make You a Millionaire

More Articles

Volume:

Previous Close -

Market Cap 10.28B

PE Ratio 134.70

EPS 0.52

Volume (Avg. Vol.) 1.96M

Day's Range $69.70 - $71.97

52-Week Range $53.79 - $94.86

Dividend & Yield $0.20 (0.29%)

BRKR Stock Predictions, Articles, and Bruker Corp News

From InvestorPlace
From the Web

7 A-Rated Healthcare Stocks to Buy for the Long Haul

By Louis Navellier and the InvestorPlace Research Staff Nov 1, 2021

It looks like we're on the back end of the Covid pandemic, so it's a good time to look at healthcare stocks that have a big future.

7 Manufacturing Stocks to Buy for a Solid Foundation

By Ian Bezek, InvestorPlace Contributor Sep 29, 2020

The global trade winds are shifting. That should be good news for domestic industry, and these seven manufacturing stocks in particular.

Bruker (BRKR) a Buy on Strong Quant Score

By Portfolio Grader Nov 9, 2017

Bruker Corp (NASDAQ:BRKR) is classified as a component of the 33 company Life Sciences Tools & Services GICS industry group, which is part of the 785 company GICS Health Care sector. BRKR's market value is $5.3 billion which falls in the upper half of its industry group. The ranking for BRKR by Portfolio Grader places it 9 among the 33 companies in this industry group, placing it in the top half; in the top quartile of the sector with a ranking of 98 among the 785 companies in the sector, and number 641 in the nearly 5,000 company Portfolio Grader universe.

11 Life Sciences Tools & Services Stocks to Sell Now

By Portfolio Grader Dec 22, 2016

The overall ratings of 11 Life Sciences Tools & Services stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

7 Life Sciences Tools & Services Stocks to Sell Now

By Portfolio Grader Dec 15, 2016

This week, the overall grades of 7 Life Sciences Tools & Services stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

5 Stocks With Superb Operating Margin — PLAB BRKR CACB CTIB BBW

By Portfolio Grader May 30, 2016

This week, these five stocks have the best ratings in Operating Margin, one of the eight Fundamental Categories on Portfolio Grader.

5 Stocks With Prime Operating Margin — PLAB BRKR CTIB BBW SCS

By Portfolio Grader May 23, 2016

This week, these five stocks have the best ratings in Operating Margin, one of the eight Fundamental Categories on Portfolio Grader.

5 Stocks With Great Operating Margin — PLAB BRKR MSCC CTIB BBW

By Portfolio Grader May 16, 2016

This week, these five stocks have the best ratings in Operating Margin, one of the eight Fundamental Categories on Portfolio Grader.

5 Stocks With Great Operating Margin — PLAB BRKR MSCC CTIB BBW

By Portfolio Grader May 9, 2016

This week, these five stocks have the best ratings in Operating Margin, one of the eight Fundamental Categories on Portfolio Grader.

5 Stocks With Superb Operating Margin — PLAB BRKR MSCC PYDS BBW

By Portfolio Grader May 2, 2016

This week, these five stocks have the best ratings in Operating Margin, one of the eight Fundamental Categories on Portfolio Grader.

7 A-Rated Stocks With Rock-Solid Foundations

By Louis Navellier, Editor, Growth Investor Apr 22, 2016

Buy stocks that can endure this middling market. Regardless of sector, what matters is how well they grow when growth is scarce to come by.

Bruker to buy ELITechGroup for €870M (NASDAQ:BRKR)

From Seeking Alpha Feb 28, 2024

Bruker Corporation plans to acquire ELITechGroup for €870M in cash, with the transaction expected to close in Q2 2024.

JP Morgan upgrades Bruker to overweight, cites guidance (NASDAQ:BRKR)

From Seeking Alpha Feb 14, 2024

JP Morgan upgraded Bruker (BRKR) to overweight, citing its better-than-expected 2024 guidance and pull-forward of its 2026 revenue and non-GAAP EPS LRP targets

Bruker acquires Spectral Instruments Imaging company (NASDAQ:BRKR)

From Seeking Alpha Feb 6, 2024

Bruker Corporation has acquired Spectral Instruments Imaging, expanding its preclinical imaging portfolio in in-vivo optical imaging.

Bruker announces agreement to buy Chemspeed (NASDAQ:BRKR)

From Seeking Alpha Jan 25, 2024

Bruker Corporation acquires Chemspeed Technologies to speed up lab automation and digitalization, enhancing their scientific software solutions.

Biognosys expands US footprint with Massachusetts proteomics CRO facility (NASDAQ:BRKR)

From Seeking Alpha Jan 23, 2024

Biognosys expands its US presence with a new proteomics facility in Massachusetts, enhancing proximity to American customers.

SVB Securities Remains a Buy on Bruker (BRKR)

From TipRanks Nov 7, 2022

SVB Securities analyst Puneet Souda maintained a Buy rating on Bruker (BRKR – Research Report) on November 3 and set a price target of $75.00. The company&#82...

ADVERTISEMENT